fbpx

Category

Lundbeckfonden Emerge
Lundbeck Foundation is investing a further DKK 15 million in Aarhus-based Insusense Therapeutics, a biotech company which develops new drugs for the treatment of type 2 diabetes and obesity.
Lundbeck Foundation has decided to invest DKK 300 million in Danish biotech companies over the next four years. The funds will be invested by Lundbeckfond Emerge with the aim of generating a portfolio of five active companies over the course of a couple of years.
1 2

Nyheder

New test exposes dangerous moles
14. February 2020
Asthma is programmed early in life
7. February 2020
A female dog may well be the answer
24. January 2020

Lundbeckfonden

Lundbeckfonden Ventures

Lundbeckfonden Emerge